Have a personal or library account? Click to login
Enediyne compounds - new promises in anticancer therapy Cover

Enediyne compounds - new promises in anticancer therapy

Open Access
|May 2007

References

  1. X. L. Yang and A. H.-J. Wang, Structural studies of atom-specific anticancer drugs acting on DNA, Pharmacol. Therapeut.83 (1999) 181-215; DOI: 10.1016/S0163-7258(99)00020-0.10.1016/S0163-7258(99)00020-0
  2. N. A. Illan-Cabeza, R. A. Vilaplana, Y. Alvarez, K. Akdi, S. Kamah, F. Hueso-Urena, M. Quiros, F. Gonzalez-Vilchez and M. N. Moreno-Carretero, Synthesis, structure and biological activity of a new and efficient Cd(II)-uracil derivative complex system for cleavage of DNA, J. Biol. Inorg. Chem.10 (2005) 924-934; DOI: 10.1007/s00775-005-0045-x.10.1007/s00775-005-0045-x
  3. I. Haq and J. Ladbury, Drug-DNA recognition: Energetics and implications for design, J. Mol. Recognit.13 (2000) 188-197; DOI: 10.1002/1099-1352(200007/08)13:4<;188::AID-JMR503>3.0.CO;2-1.10.1002/1099-1352(200007/08)13:4<;188::AID-JMR503>3.0.CO;2-1
  4. R. Barthwal, U. Sharma, N. Snivastava, M. Jain, P. Awasthi, M. Kaur, S. K. Barthwal and G. Govil, Structure of daunomycin complexed to d-TGATCA by two-dimensional nuclear magnetic resonance spectroscopy, Eur. J. Med. Chem.41 (2006) 27-39; DOI: 10-1016/j.ejmech.2005.09.005.10.1016/j.ejmech.2005.09.005
  5. J. Chen and J. Stubbe, Bleomycins: new methods will allow reinvestigation of old issues, Curr. Opin. Chem. Biol.8 (2004) 175-181; DOI: 10.1016/j.cbpa.2004.02.008.10.1016/j.cbpa.2004.02.008
  6. S. E. Wolkenberg and D. L. Boger, Mechanisms of in situ activation for DNA-targeting antitumor agents, Chem. Rev.102 (2002) 2477-2495; DOI: 10.1021/cr010046q.10.1021/cr010046q
  7. Y. L. Janin, Peptides with anticancer use or potential, Amino Acids25 (2003) 1-40; DOI 10.1007/s00726-002-0349-xPeptides.10.1007/s00726-002-0349-x
  8. I. Jerić, L. Šimičić, M. Stipetić and Š. Horvat, Synthesis and reactivity of the monosaccharide esters of amino acids as models of teichoic acid fragment, Glycoconjugate J.17 (2000) 273-282; DOI: 10.1023/A:1007157018792.10.1023/A:1007157018792
  9. I. Jerić and Š. Horvat, Novel ester-linked carbohydrate-peptide adducts: Effect of peptide substituent on the pathways of intramolecular reactions, Eur. J. Org. Chem. (2001) 1533-1539; DOI: 10.1002/1099-0690(200104)2001:8<;1533::AID-EJOC1533>3.0.CO;2-Y.10.1002/1099-0690(200104)2001:8<;1533::AID-EJOC1533>3.0.CO;2-Y
  10. I. Jerić, P. Novak, M. Vinković and Š. Horvat, Conformational analysis of sugar-peptide adducts in solution state by NMR spectroscopy and molecular modelling, J. Chem. Soc., Perkin Trans 22001, 1944-1950; DOI: 10.1039/b104239b.10.1039/b104239b
  11. Š. Horvat, I. Jerić, L. Varga-Defterdarović, M. Roščić and J. Horvat, Ester-linked glycopeptides as tools for the study of biological phenomena, Croat. Chem. Acta74 (2001) 787-799.
  12. I. Jerić, C. Versluis, Š. Horvat and A. J. R. Heck, Tracing glycoprotein structures: electrospray ionization tandem mass spectrometric analysis of sugar-peptide adducts, J. Mass Spectrom.37 (2002) 803-811; DOI: 10.1002/jms.337.10.1002/jms.33712203674
  13. I. Jerić and Š. Horvat, Glycoconjugates as models in biomedical studies, Kem. Ind.53 (2004) 63-70.
  14. I. Jerić, Peptide mimetics: why and how? Kem. Ind.53 (2004) 495-504.
  15. I. Jerić and H. M. Chen, Synthesis of an Enedyine-bridged Peptide for Cell Lysis, in Peptides 2004. Bridges Between Disciplines (Eds. M. Flegel, M. Fridkin, C. Gilon and J. Slaninova), Kenes International, Geneva 2005, pp. 218-219.
  16. I. Jerić, M. Momčilović, I. Bratoš and Š. Horvat, Synthesis of trehalose-centered dipeptide esters, Croat. Chem. Acta79 (2006) 261-272.
  17. K. C. Nicolaou, A. L. Smith, and E. W. Yue, Chemistry and biology of natural and designed enediynes, Proc. Nat. Acad. Sci. USA90 (1993) 5881-5888.10.1073/pnas.90.13.5881468308327459
  18. A. L. Smith and K. C. Nicolaou, The enediyne antibiotics, J. Med. Chem.39 (1996) 2103-2117; DOI: 10.1021/jm9600398.10.1021/jm96003988667354
  19. K. Edo, M. Mizugaki, Y. Koide, H. Seto, K. Furihata, N. Otake and N. Ishida, The structure of neocarzinostatin chromophore possessing a novel bicyclo-[7,3,0]dodecadiyne system, Tetrahedron Lett.26 (1985) 331-334; DOI: 10.1016/S0040-4039(1)80810-8.
  20. M. D. Lee, T. S. Dunne, C. C. Chang, G. A. Ellestad, M. M. Siegel, G. O. Morton, W. J. McGahren and D. B Borders, Calichemicins, a novel family of antitumor antibiotics. 2. Chemistry and structure of calichemicin gamma1I, J. Am. Chem. Soc.109 (1987) 3466-3468; DOI: 10.1021/ja00245a051.10.1021/ja00245a051
  21. J. Golik, J. Clardy, G. Dubay, G. Groenwold, H. Kawaguchi, M. Konishi, B. Krishnan, H. Ohkuma, K. Saitoh and T. W. Doyle, Esperamicins, a novel class of potent antitumor antibiotics. 2. Structure of esperamicin X, J. Am. Chem. Soc.109 (1987) 3461-3462; DOI: 10.1021/ja00245a048.10.1021/ja00245a048
  22. M. Konishi, H. Ohkuma, T. Tsuno, T. Oki, G. D. VanDuyne and J. Clardy, Crystal and molecular structure of dynemicin A: A novel 1,5-diyn-3-ene antitumor antibiotic, J. Am. Chem. Soc.112 (1990) 3715-3716; DOI: 10.1021/ja00165a097.10.1021/ja00165a097
  23. R. R. Jones and R. G. Bergman, p-Benzyne: Generation as an intermediate in a thermal isomerization reaction and trapping evidence for the 1,4-benzenediyl structure. J. Am. Chem. Soc.94 (1972) 660-661; DOI: 10.1021/ja00757a071.10.1021/ja00757a071
  24. P. C. Dedon, A. A. Salzberg and J. Xu, Exclusive production of bistranded DNA damage by calicheamicin, Biochemistry32 (1993) 3617-3622; DOI: 10.1021/bi00065a013.10.1021/bi00065a0138466904
  25. J. W. Grissom, G. U. Gunawardena, D. Klingberg and D. Huang, The chemistry of enediynes, enyne, allens and related compounds, Tetrahedron52 (1996) 6453-6518; DOI: 10.1016/0040-4020 (96)00016-6.
  26. E. W. Schmitt, J. C. Huffman and J. M. Zaleski, Thermal reactivities of isostructural d10 metal-loenediynes: metal-dependent Bergman cyclization, Chem. Commun. 2001, 167-168; DOI: 10.1039/b008337m.10.1039/b008337m
  27. I. Saito and K. Nakatani, Design of DNA-cleaving agents, Bull. Chem. Soc. Jpn.69 (1996) 3007-3019; DOI: 10.1246/bcsj.69.3007.10.1246/bcsj.69.3007
  28. H. H. Wenk, M. Winkler and W. Sander, One century of aryne chemistry, Angew. Chem. Int. Ed.42 (2003) 502-528; DOI: 10.1002/anie.200390151.10.1002/anie.20039015112569480
  29. K. C. Nicolaou, G. Zuccarello, C. Riemer, V. A. Estevez and W.-M. Dai, Design, synthesis and study of simple monocyclic conjugated - enediynes. The 10-membered ring enediyne moiety of the enediyne anticancer antibiotics, J. Am. Chem. Soc.114 (1992) 7360-7371; DOI: 10.1021/ja00045a005.10.1021/ja00045a005
  30. M. E. Maier and T. Brandstetter, Synthesis of an oxabicyclo[7.2.1.] enediyne from a furanoside derivative, Tetrahedron Lett.33 (1992) 7511-7514; DOI: 10.1016/s0040-4039(00)60-810-9.
  31. S. Bhattacharyya, M. Pink, M.-H. Baik and J. M. Zaleski, A unique approach to metal-induced Bergman cyclization: long range enediyne activation by ligand-to-metal charge transfer, Angew. Chem. Int. Ed.44 (2005) 592-595; DOI: 10.1002/anie.200461825.10.1002/anie.20046182515586394
  32. D. L. Boger and J. Zhou, CDPI3-enediyne and CDPI3-EDTA conjugates: a new class of DNA cleaving agents, J. Org. Chem.58 (1993) 3018-3024; DOI: 10.1021/jo0006a019.
  33. N. Ishida, K. Miyazaki, K. Kumagai and M. Rikimaru, Neocarzinostatin, an antitumor antibiotic of high molecular weight, J. Antibiot.18 (1965) 68-76.
  34. M. F. Semmelhack, J. J. Gallagher, W.-D. Ding, G. Krishnamurthy, R. Babine and G. A. Ellestad, The effect on DNA cleavage potency of tethering a simple cyclic enediyne to a netropsin analog, J. Org. Chem.59 (1994) 4357-4359; DOI: 10.1021/jo00095a002.10.1021/jo00095a002
  35. N. Zein, A. M. Casazza, T. W. Doyle, J. E. Leet, D. R. Schroeder, W. Solomon and S. G. Nadler, Selective proteolitic activity of the antitumor agent kedarcidin, Proc. Nat. Acad. Sci. USA90 (1993) 8009-8012; DOI: 10.1073/pnas.90.17.8009.10.1073/pnas.90.17.8009472778367457
  36. C. G. Sudhahar and D. H. Chin, Aponeocarzinostatin - A superior drug carrier exhibiting unusually high endurance against denaturants, Bioorg. Med. Chem.14 (2006) 3543-3552; DOI: 10.1016/j.bmc.2006.01.012.10.1016/j.bmc.2006.01.01216458518
  37. N. F. Schor, V. E. Kagan, Ye Liang, Ch. Yan, Yu. Tyurina, V. Tyurin and K. D. Nylander, Exploiting oxidative stress and signaling in chemotherapy of resistant neoplasms, Biochemistry (Moscow) 69 (2004) 38-44; DOI: 10.1023/B:BIRY.0000016349.75384.e6.10.1023/B:BIRY.0000016349.75384.e6
  38. N. Zein, M. Poncin, R. Nilakantan and G. A. Ellestad, Calicheamicin γI1 and DNA: Molecular recognition process responsible for site-specificity; Science244 (1989) 697-699.
  39. S. Walker, J. Murnick and D. Kahne, Structural characterization of a calicheamicin-DNA complex by NMR, J. Am. Chem. Soc.115 (1993) 7954-7961; DOI: 10.1021/ja00071a004.10.1021/ja00071a004
  40. N. K. Damle, Tumour-targeted chemotherapy with immunoconjugates of calicheamicin, Expert Opin. Biol. Ther.4 (2004) 1445-1452; DOI: 10.1517/14712598.4.9.1445.10.1517/14712598.4.9.144515335312
  41. K. C. Nicolaou and W.-M. Dai, Chemistry and biology of the enediyne anticancer antibiotics, Angew. Chem. Int. Ed.30 (1991) 1387-1416; DOI: 10.1002/anie.199113873.10.1002/anie.199113873
  42. S. Feldgus, Expanding the cancer fighting arsenal, http://www.hamilton.edu/enews/200202.html
  43. S. C. Sinha, Lian-Sheng Li, G. P. Miller, S. Dutta, C. Rader and R. A. Lerner, Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldose catalytic Ab, Proc. Nat. Acad. Sci. USA9 (2004) 3095-3099; DOI: 10.1073/pnas.0307319101.10.1073/pnas.030731910136574914981258
  44. Y. Suguira, T. Shiraki, M. Konishi and T. Oki, DNA Intercalation and cleavage of an antitumor antibiotic dynemicin that contains anthracycline and enediyne cores, Proc. Nat. Acad. Sci. USA87 (1990) 3831-3835; DOI: 10.1073/pnas.87.10.3831.10.1073/pnas.87.10.3831539972339123
DOI: https://doi.org/10.2478/v10007-007-0011-y | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 133 - 150
Published on: May 16, 2007
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2007 Matija Gredičak, Ivanka Jerić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 57 (2007): Issue 2 (June 2007)